IDH1 and astrocytoma (excluding glioblastoma): In their series, patients harboring a non-canonical IDH1 mutation were more frequently astrocytomas (65.6 vs. 43%), while patients with IDH1 mutations were often oligodendrogliomas (85 vs. 48.3%).